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Abstract 
Aims/hypothesis 
Diabetes in pregnancy is linked to development of obesity in the offspring, but the 
mechanisms are not fully understood. Gestational diabetes mellitus (GDM) occurs when beta 
cells are unable to compensate for the normal insulin resistance of late pregnancy. In this 
study, we used a murine model of beta cell dysfunction to examine the effects of maternal 
GDM on phenotype in male offspring with and without an inherited predisposition for beta 
cell dysfunction. 
Methods 
Beta cell-specific aryl-hydrocarbon receptor nuclear translocator-null (βArnt) mice develop 
GDM from beta cell dysfunction. βArnt and control female mice were used to induce GDM 
and non-diabetic pregnancies, respectively. 
Results 
Offspring from GDM pregnancies became spontaneously obese on a normal-chow diet. They 
were heavier than offspring from non-diabetic pregnancies, with increased body fat. 
Respiratory exchange ratio (RER) was higher, indicating decreased capacity to switch to lipid 
oxidation. Metabolic rate in GDM offspring was decreased prior to onset of obesity. The 
phenotype was more pronounced in βArnt GDM offspring than in GDM offspring of control 
genotype, demonstrating an interaction between genotype and pregnancy exposure. βArnt 
GDM offspring had increased hypothalamic neuropeptide Y (Npy) and decreased pro-
opiomelanocortin (Pomc) expression. Weight, body fat, insulin sensitivity and RER in all 
mice, and hypothalamic Npy in βArnt mice were significantly correlated with AUC of 
maternal late pregnancy glucose tolerance tests (p  <  0.01), but not with litter size, maternal 
weight, triacylglycerol or pre-pregnancy glycaemia. 
Conclusions/interpretation 
In βArnt mice, exposure to GDM and inheritance of genetic beta cell dysfunction had additive 
effects on male offspring obesity; severity of the offspring phenotype correlated with maternal 
glycaemia. 
 
Abbreviations 
AUCGTT - AUC for GTT  ; AUCITT - AUC for ITT; βArnt - Beta cell-specific aryl hydrocarbon  receptor nuclear translocator 
null mice  ; db –/+ - Leptin receptor heterozygous null mice; DEXA - Dual energy X-ray absorptiometry; dns - Data not shown; 
GDM -  Gestational diabetes mellitus; GK - Goto–Kakizaki; GSIS - Glucose-stimulated insulin secretion; GTT -   Glucose 
tolerance test; ITT - Insulin tolerance test  ; NDP - Non-diabetic pregnancy  ; NPY – Neuropeptide Y; RER -Respiratory exchange 
ratio  ; RIP   - Rat insulin promoter; VCO2 – Carbon dioxide production; VO2 – Oxygen consumption 
 
Introduction 
Offspring of women with diabetes in pregnancy are at increased risk of obesity. This is true of 
type 1 diabetes, type 2 diabetes and gestational diabetes mellitus (GDM) [1–6]. In the 
diabetes-prone North American Pima Indians, children born after the onset of maternal type 
2 diabetes had BMI 2.6 kg/m2 greater than siblings born before maternal hyperglycaemia and 
were more likely to develop diabetes [7]. The mechanisms underlying this obesity are not fully 
elucidated. It has proven difficult to separate the effects of genetic risk and exposure. 
Improving our understanding of these mechanisms could help to break the cycle of diabetes 
and obesity begetting diabetes and obesity, an important contributor to the exponential rise in 
these conditions worldwide [1, 4, 6, 7]. 
 Women become insulin-resistant in the later stages of normal pregnancy. GDM 
develops when beta cell function cannot compensate for the degree of insulin resistance [8, 9]. 
Animal models can help determine the contributions of genes, postnatal and early life to 
offspring phenotypes. Previous studies have investigated the effects of maternal 
hyperglycaemia using Goto–Kakizaki (GK) rats and leptin receptor heterozygous knockout 
Lau	  et	  al.:	  Diabetologia	  54	  (4):	  910-­‐921,	  2011	  	  
(db–/+) mice [10]. Transfer of GK embryos to normal mothers did not restore offspring 
glucose tolerance, whereas exposure of normal embryos to GK mothers caused glucose 
intolerance [11]. Db/+ mothers, which have greater fat pad weights than their wild-type 
controls, produce db–/+ offspring with a more pronounced phenotype than db–/+ offspring 
born to wild-type mothers, showing that exposure to mild maternal obesity worsens offspring 
phenotype [10]. However, db–/+ mice have normal glucose tolerance, so cannot serve as a 
model of GDM. Models of maternal overfeeding [12] can produce GDM and are very relevant 
to the obesity epidemic, but it is not possible to separate contributions of maternal diet, 
obesity and glucose tolerance. 
 Genetic beta cell dysfunction such as that caused by the MODY syndromes causes 
early-onset glucose intolerance, sometimes diagnosed during pregnancy [13]. Polymorphisms 
in genes that regulate beta cell function are also associated with GDM [14–16]. As many 
women with GDM will have a genetic predisposition to diabetes, which may or may not be 
passed on to their offspring, a model that separates the effects of hyperglycaemia, 
intergenerational effects and inherited genetic risk would be useful. In addition, it has long 
been debated which nutrients or defects are responsible for offspring effects [17], and a model 
with deficits only in insulin-secreting cells would help to answer this question. 
The beta-cell-specific aryl-hydrocarbon receptor nuclear translocator-null (βArnt) mouse is a 
model of beta cell dysfunction with normal fasting glucose and mildly impaired glucose 
tolerance [18]. We previously reported a 90% reduction in ARNT mRNA in islets from 
patients with type 2 diabetes [18]. Of the five patients with type 2 diabetes in that study, three 
were women with a known history of GDM. Because the beta cell defect in βArnt mice is 
inherited in an autosomal dominant manner, it allows examination of the effects of maternal 
glucose intolerance in offspring with and without inherited beta cell dysfunction. This mimics 
the human situation, where some children inherit their parents’ susceptibility genes and some 
do not. The defect is specific to insulin-expressing cells, so allows examination of the effects of 
abnormalities isolated to this population of cells. 
 Using this mouse model, the aims of this study were: (1) to examine the mechanisms 
underlying development of obesity in offspring of GDM mothers; and (2) to examine the 
interactions between GDM exposure and inherited genetic beta cell defects in offspring risk. 
Exposure to GDM resulted in spontaneous obesity on normal-chow diet, with a more severe 
phenotype in βArnt than in floxed-control offspring. GDM offspring had increased body fat 
and respiratory exchange ratio (RER), and decreased energy expenditure. Maternal glycaemia 
in pregnancy correlated significantly with offspring weight, insulin insensitivity and RER, and 
in βArnt mice with hypothalamic neuropeptides. 
 
Methods 
 
Mice 
βArnt mice were generated as previously reported [19] and bred at Australian BioResources 
(Mossvale, NSW, Australia). All mice were homozygous Arnt-floxed. The beta cell defect is 
inherited with one Cre-recombinase allele driven by the rat insulin promoter (RIP). RIP-
Cre(+) mice delete Arnt in insulin-expressing cells (flox/flox, RIP-Cre(+) mice  =  βArnt) and 
RIP-Cre(−) mice do not (flox/flox, RIP-Cre(−) mice  =  floxed-controls). In our colony, RIP-Cre 
transgenic mice have unaltered glucose tolerance vs wild-type or Arnt-flox/flox controls 
(p  >  0.6 for all time points, data not shown (dns)). Studies were approved by the Garvan 
Animal Ethics Committee. 
 Figure 1a outlines the breeding plan and Fig. 1b,	  c the timelines for offspring 
experiments. To induce GDM pregnancies, 12- to 16-week-old βArnt female mice were mated 
with floxed-control males. Floxed-control females were mated with βArnt males to produce 
non-diabetic pregnancy (NDP). Day of conception was determined by confirmation of vaginal 
plugging the following morning. Glucose tolerance test (GTT) was performed at gestational 
day 16.5 as described below. All mice had free access to chow (energy from fat 8%, from 
protein 21%, from carbohydrate 71%, 10.6 kJ/g; Gordon’s Specialty Stock Feeds, Yanderra, 
NSW, Australia). Two separate adult offspring cohorts of six βArnt and six floxed-control 
females were set up for each cohort to ensure feasibility, starting ∼8 weeks apart and the 
results are combined. After offspring obesity was found in the cohorts indicated in Fig. 1b,	  a 
third cohort (Fig. 1c) was started and killed at 6 weeks. The aim for this cohort was to look for 
changes occurring prior to obesity development, which might therefore be causal rather than 
secondary to obesity. 
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Offspring 
Litters with fewer than five pups were excluded from analysis, with three litters being 
excluded each time. Large litters were reduced to seven pups on day 1.5. Pups were weighed at 
1.5 days of age and returned to their mothers. Weaning was at 25 days, after which male 
offspring were weighed every 7–10 days until being killed. 
 
Quantification of food intake 
Following acclimatisation to single-housing in cages with absorbent towels rather than usual 
bedding, food consumption and faecal output were measured daily for 3 consecutive days. 
 
(Spearman) correlations were used. Means ± SEM are
shown. Statistical analysis was performed using SPSS
14.0 (SPSS, Chicago, IL, USA). A p value of p<0.05 was
considered statistically significant.
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Fig. 1 Experimental plans. a Breeding plan for βArnt (from GDM
pregnancies) and floxed-control (from control pregnancies) females. b
Timeline for testing of mothers and their offspring (adult cohorts). All
male offspring were weighed at weaning and every 7 to 10 days
thereafter. Glucose metabolic testing is denoted by white triangles:
GTT was performed at 8 and 16 weeks, ITT at 15 weeks and GSIS test
at 17 weeks of age. DEXA scanning (white circles) was performed at
12 weeks. Food intake (black triangles) was measured at 15 weeks.
Physiological tests were spaced in order to minimise mouse stress and
allow recovery between studies, with 1 week between ITT, GTT and
GSIS at 15, 16 and 17 weeks of age. Offspring were studied in two
separate cohorts, about 8 weeks apart, and results were pooled. Results
were similar in the two cohorts. Mice were killed at least 3 weeks after
the 17 week GSIS. c Timeline for testing of early male offspring
phenotype (6 week pre-obese offspring cohort). Offspring were
derived from 15 GDM pregnancies and ten non-diabetic pregnancies.
Food intake (black triangle) was measured at 5.5 weeks. Half of the
mice were killed at 6 weeks of age for collection of plasma and brains
for in situ hybridisation. The rest underwent indirect calorimetry
(black square) and DEXA scanning (white circle) before killing
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Indirect calorimetry 
Calorimetry was performed for 24 h after 24 h acclimatisation (Oxymax Respirometer 0246-
002 M; Columbus Instruments, Columbus, OH, USA), as described previously [20]. Free 
access to food and water was provided. Ambulatory activity was measured using an activity 
meter (Opto-M3; Columbus Instruments) [20]. RER was calculated as oxygen consumption 
(VO2 )/ carbon dioxide production (VCO2)[21].   Energy expendi ture (kJ heat produced) was 
calculated as calorific value (CV) × VO2, where CV=15.966+5.156×RER. VO2 and VCO2 are 
expressed corrected for lean body weight, which was measured by dual energy X-ray 
absorptiometry (DEXA). DEXA was performed within 48 h of calorimetry using a Lunar 
PIXImus2 (GE Healthcare, Port Washington, NY, USA) as previously reported [20]. 
Glucose and insulin tolerance tests 
Tests were performed after overnight 16 h fasts using a glucometer (Accucheck; Roche, 
Sydney, NSW, Australia). GTTs employed 2 g/kg of i.p. glucose as previously reported [18]. 
Glucose-stimulated insulin secretion (GSIS) was measured following administration of 
3 g/kg i.p. glucose [18, 22]. Insulin tolerance tests (ITT) used 0.5 units/kg insulin i.p. as 
previously reported [23]. 
 
Tissue and blood collection 
Animals were killed after a 16 h fast. Blood was collected. Brains were frozen on dry ice and 
stored at −70°C. Epigonadal fat was collected and snap frozen in liquid nitrogen. 
 
Assays 
Serum insulin and leptin were assayed by ELISA (Crystal Chem, Downers Grove, IL, USA) as 
per manufacturer’s instructions. Fasting triacylglycerol was assayed using a colorimetric assay 
(Roche). 
 
Gene expression 
Tissue was homogenised in lysis buffer (RLT; Qiagen, Valencia, CA, USA). RNA was extracted 
as previously described [18]. Real-time PCR was performed using SYBR Green (Applied 
Biosystems, Foster City, CA, USA) as previously described [18] with a real-time PCR system 
(ABI 7900HT; Applied Biosystems) (primer sequences available on request). 
 
Brain cryosection and in situ hybridisation 
After Tissue-Tek (Qiagen) embedding, 20 µm coronal sections of the brain covering the 
arcuate nucleus were cut. Three sections per mouse (three sections apart) were mounted per 
slide and stored at −20°C. One slide per mouse was used for each neuropeptide for in situ 
hybridisation, which was performed as previously described [24]. NIH 1.65 software 
(http://rsbweb.nih.gov.ezproxy1.library.usyd.edu.au/ij/, accessed 1 December 2009) was 
used to calculate mean signal density, and slides were dipped in emulsion and counterstained 
with haematoxylin [24]. 
 
Statistical analysis 
Two-way ANOVA was used to assess interaction between pregnancy type and offspring 
genotype. Where interaction was detected, βArnt and control offspring were analysed 
separately. Characteristics were compared using unpaired t tests unless specified. Bivariate 
(Spearman) correlations were used. Means ± SEM are shown. Statistical analysis was 
performed using SPSS 14.0 (SPSS, Chicago, IL, USA). A p value of p  <  0.05 was considered 
statistically significant. 
 
Results 
 
βArnt mothers had poorer glucose tolerance in pregnancy 
The breeding plan is shown in Fig. 1a. βArnt dams had normal fasting glucose and mildly 
worse glucose tolerance pre-pregnancy, consistent with our previous report [18]. βArnt dams 
had normal fertility and litter sizes (6.7  ±  0.5 vs 6.3  ±  0.4 pups per litter in floxed-controls) 
and remained well during pregnancy. Maternal weight in late pregnancy did not differ 
significantly (31.9  ±  0.8 vs 30.8  ±  1.1 g, p  >  0.4). 
Fasting glucose did not differ, but glucose levels after glucose loading (GTT) deteriorated 
significantly at all time points in pregnancy in βArnt mice (p  <  0.05, t test). In floxed-control 
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mothers, glucose tolerance deteriorated, but not to the same extent. Thus pregnant βArnt 
females had higher glucose levels than pregnant floxed-control females at all time points 
except fasting (Fig. 2a). Figure 2b shows total AUCs for GTT (AUCGTT) (p  <  0.01 for pregnant 
βArnt vs pregnant floxed-controls). 
 
 We have previously reported that insulin secretion is impaired in non-gravid βArnt 
females [18]. Pregnant βArnt females had similar fasting insulin (14.5  ±  3.3 vs 12.4  ±  2.2 
pmol/l, p  =  NS), but during pregnancy first-phase insulin secretion was reduced (increase of 
140  ±  57% vs 653  ±  222% in floxed-controls, p  <  0.05). This is similar to the responses outside 
of pregnancy. βArnt dams had no differences in circulating fasting triacylglycerol levels 
(23.2  ±  2.0 vs 29.4  ±  4.0 mmol/l, p  =  0.17) and there was no correlation between maternal 
AUCGTT and fasting triacylglycerol. 
 
Maternal GDM resulted in increased offspring weight and adiposity 
Similar to human offspring of women with GDM, pups born to GDM mothers were 
significantly heavier at 1.5 days of age (1.66  ±  0.02 vs 1.57  ±  0.03 g, p  =  0.02). Pups were not 
genotyped at this age due to risk of maternal rejection. Instead, genotyping was done at 
weaning and pups were then placed on a normal-chow diet. Genotyping showed that NDP 
βArnt offspring were ∼10% lighter than GDM ßArnt mice (12.7  ±  0.5 vs 11.6  ±  0.3 g, 
had normal fasting glucose and mildly worse glucose
tolerance pre-pregnancy, consistent with our previous
report [18]. βArnt dams had normal fertility and litter
sizes (6.7±0.5 vs 6.3±0.4 pups per litter in floxed-
controls) and remained well during pregnancy. Maternal
weight in late pregnancy did not differ significantly (31.9±
0.8 vs 30.8±1.1 g, p>0.4).
Fasting glucose did not differ, but glucose levels after
glucose loading (GTT) deteriorated significantly at all time
points in pregnancy in βArnt mice (p<0.05, t test). In
floxed-control mothers, glucose tolerance deteriorated, but
not to the same extent. Thus pregnant βArnt females had
higher glucose levels than pregnant floxed-control females
at all time points except fasting (Fig. 2a). Figure 2b shows
total AUCs for GTT (AUCGTT) (p<0.01 for pregnant
βArnt vs pregnant floxed-controls).
We have previously reported that insulin secretion is
impaired in non-gravid βArnt females [18]. Pregnant
βArnt females had similar fasting insulin (14.5±3.3 vs
12.4±2.2 pmol/l, p=NS), but during pregnancy fir t-phase
insulin secretion was reduced (increase of 140±57% vs
653±222% in floxed-controls, p<0.05). This is similar to
the responses outside of pregnancy. βArnt dams had no
differences in circulating fasting triacylglycerol levels
(23.2±2.0 vs 29.4±4.0 mmol/l, p=0.17) and there was
no correlation between maternal AUCGTT and fasting
triacylglycerol.
Maternal GDM resulted in increased offspring weight and
adiposity Similar to human offspring of women with
GDM, pups born to GDM mothers were significantly
heavier at 1.5 days of age (1.66±0.02 vs 1.57±0.03 g, p=
0.02). Pups were not genotyped at this age due to risk of
maternal rejection. Instead, genotyping was done at wean-
ing and pups were then placed on a normal-chow diet.
Genotyping showed that NDP βArnt offspring were ∼10%
lighter than GDM ßArnt mice (12.7±0.5 vs 11.6±0.3 g, p=
0.034). Floxed-controls were not different (12.3±0.4 vs
12.4±0.2 g). Offspring of GDM gained more weight than
NDP offspring (p<0.0001 by ANOVA for repeated
measures) resulting in increased body weight from 8 weeks
of age (p<0.001 by ANOVA for repeated measures)
(Fig. 3a). Interestingly, the increased weight was more
pronounced in βArnt GDM offspring than in floxed-control
GDM offspring (Fig. 3a) (p<0.01 by ANOVA for repeated
measures), showing an interaction between genotype and in
utero exposure. There was no difference in weight at any
time point between βArnt NDP offspring and floxed-
control NDP offspring. Maternal gestational glucose toler-
ance (AUCGTT) and offspring weight were correlated, with
worse maternal glucose tolerance associated with higher
offspring weight (Fig. 3b). Results are shown for 15-week-
old offspring (p<0.0002), but this correlation was also
consistently significant (p<0.05) from 13 through to
19 weeks of age.
At 6 weeks of age, 2 weeks before overall weight began
to differ in GDM vs NDP offspring, body fat was lower in
NDP floxed-controls than in the other three groups (13±1%
vs 15±1% in control GDM, 15±1% in βArnt NDP and 15
±1% in βArnt GDM offspring, p=0.02). Maternal gesta-
tional glucose tolerance (AUCGTT) and offspring body fat
at 6 weeks of age were correlated (r2=0.21, p=0.02,
Spearman bivariate correlation). Fasting serum leptin levels
at 6 weeks were consistent with body fat composition:
leptin was similar in βArnt GDM (1.38±0.32 μg/l), βArnt
NDP (1.47±0.64 μg/l) and floxed-control GDM (1.25±
0.41 μg/l), but was significantly lower in floxed-control
NDP (0.37±0.16 μg/l, p<0.01).
Figure 3c shows that by 12 weeks, body fat was 27%
greater (95% CI 1.09–1.48-fold) in GDM vs NDP offspring
(p=0.002). βArnt offspring had 33% greater body fat than
floxed-controls (95% CI 1.14–1.55-fold) (p<0.001, two-
way ANOVA). Lean mass contribution was non-
significantly lower in GDM than NDP offspring.
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Fig. 2 βArnt mice are a model of maternal glucose intolerance in
pregnancy. a Pre-gravid and late gestational GTT for βArnt (n=19)
and floxed-control (n=19) females. Data presented as means±SEM;
**p<0.01 for pregnant βArnt vs pregnant floxed-control. Black
diamonds, pre-gravid floxed-control; white diamonds, pregnant
floxed-control; black triangles, pre-gravid βArnt; white triangles,
pregnant βArnt. b Total AUCGTT. Data presented as means±SEM;
*p<0.05 and **p<0.01 for the comparisons shown. White bars, pre-
gravid floxed-control; grey bars, pregnant floxed-control; hatched
bars, pre-gravid βArnt; black bars, pregnant βArnt
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p  =  0.034). Floxed-controls were not different (12.3  ±  0.4 vs 12.4  ±  0.2 g). Offspring of GDM 
gained more weight than NDP offspring (p  <  0.0001 by ANOVA for repeated measures) 
resulting in increased body weight from 8 weeks of age (p  <  0.001 by ANOVA for repeated 
measures) (Fig. 3a). Interestingly, the increased weight was more pronounced in βArnt GDM 
offspring than in floxed-control GDM offspring (Fig. 3a) (p  <  0.01 by ANOVA for repeated 
measures), showing an interaction between genotype and in utero exposure. There was no 
difference in weight at any time point between βArnt NDP offspring and floxed-control NDP 
offspring. Maternal gestational glucose tolerance (AUCGTT) and offspring weight were 
correlated, with worse maternal glucose tolerance associated with higher offspring weight 
(Fig. 3b). Results are shown for 15-week-old offspring (p  <  0.0002), but this correlation was 
also consistently significant (p  <  0.05) from 13 through to 19 weeks of age. 
 
 
 At 6 weeks of age, 2 weeks before overall weight began to differ in GDM vs NDP 
offspring, body fat was lower in NDP floxed-controls than in the other three groups (13  ±  1% 
vs 15  ±  1% in control GDM, 15  ±  1% in βArnt NDP and 15  ±  1% in βArnt GDM offspring, 
p  =  0.02). Maternal gestational glucose tolerance (AUCGTT) and offspring body fat at 6 weeks 
of age were correlated (r2  =  0.21, p  =  0.02, Spearman bivariate correlation). Fasting serum 
leptin levels at 6 weeks were consistent with body fat composition: leptin was similar in βArnt 
GDM (1.38  ±  0.32 µg/l), βArnt NDP (1.47  ±  0.64 µg/l) and floxed-control GDM 
(1.25  ±  0.41 µg/l), but was significantly lower in floxed-control NDP (0.37  ±  0.16 µg/l, 
p  <  0.01). 
 Figure 3c shows that by 12 weeks, body fat was 27% greater (95% CI 1.09–1.48-fold) 
in GDM vs NDP offspring (p  =  0.002). βArnt offspring had 33% greater body fat than floxed-
controls (95% CI 1.14–1.55-fold) (p  <  0.001, two-way ANOVA). Lean mass contribution was 
non-significantly lower in GDM than NDP offspring. 
 
Altered gene expression in epigonadal fat 
As GDM offspring had greater body fat, we studied the expression of genes involved in lipid 
accretion and metabolism. At 6 weeks, pre-obesity, there were no significant differences 
Altered gene expression in epigonadal fat As GDM
offspring had greater body fat, we studied the expression
of genes involved in lipid accretion and metabolism. At
6 weeks, pre-obesity, there were no significant differences
(dns). In βArnt GDM adults, after the onset of obesity,
mRNA expression of the following was increased in
epigonadal fat: insulin receptor (Insr) (1.70±0.28-fold, p=
0.02); Akt2 (3.37±0.56-fold, p<0.01) and leptin (3.39±
0.50-fold, p<0.01) (Fig. 3d). In GDM floxed-controls,
Srebp-1c (also known as Srebf1) mRNA was increased
(1.52±0.18-fold, p=0.01) and there were trends towards an
increase in Fas (2.10±0.70-fold, p=0.07) and Insr (1.41±
0.17-fold, p=0.08) (Fig. 3e).
Food intake was not increased in GDM offspring The
increased adiposity of GDM offspring was not explained by
increased food consumption. Food intake was not increased
in GDM offspring and was slightly reduced in floxed-
control GDM offspring, perhaps accounting for their less
severe obesity phenotype (Fig. 4a). The faeces:food weight
ratio was reduced in 15-week-old GDM vs NDP offspring
by 0.048 g/g (95% CI 0.018–0.079 g/g) (p=0.003), with the
greatest differences observed in βArnt GDM vs βArnt NDP
offspring (Fig. 4b). This could be consistent with greater
absorption of nutrients or fluid in GDM offspring.
Interestingly, faecal output inversely correlated with mater-
nal AUCGTT, suggesting that absorptive capacity may be
influenced by in utero exposure (p<0.01, dns).
GDM offspring had decreased metabolic rate, but not
decreased locomotion GDM was associated with signifi-
cantly decreased V
!
O2 at 6 weeks (Fig. 4c). This was
associated with significantly reduced calculated energy
expenditure for the whole day, and for the light hours
during which mice usually rest (Fig. 4d). Ambulatory
activity was non-significantly higher in GDM vs NDP
offspring, so lower activity did not account for the decrease
in energy expenditure (Fig. 4e).
Respiratory exchange ratio was increased in GDM off-
spring Increased RER indicates preferential carbohydrate
over lipid oxidation, and thus a propensity for lipid
storage and increased adiposity [25]. An RER of 1.0
represents 100% carbohydrate oxidation, 0.7 represents
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(dns). In βArnt GDM adults, after the onset of obesity, mRNA expression of the following was 
increased in epigonadal fat: insulin receptor (Insr) (1.70  ±  0.28-fold, p  =  0.02); Akt2 
(3.37  ±  0.56-fold, p  <  0.01) and leptin (3.39  ±  0.50-fold, p  <  0.01) (Fig. 3d). In GDM floxed-
controls, Srebp-1c (also known as Srebf1) mRNA was increased (1.52  ±  0.18-fold, p  =  0.01) 
and there were trends towards an increase in Fas (2.10  ±  0.70-fold, p  =  0.07) and Insr 
(1.41  ±  0.17-fold, p  =  0.08) (Fig. 3e). 
 
Food intake was not increased in GDM offspring 
The increased adiposity of GDM offspring was not explained by increased food consumption. 
Food intake was not increased in GDM offspring and was slightly reduced in floxed-control 
GDM offspring, perhaps accounting for their less severe obesity phenotype (Fig. 4a). The 
faeces:food weight ratio was reduced in 15-week-old GDM vs NDP offspring by 0.048 g/g 
(95% CI 0.018–0.079 g/g) (p  =  0.003), with the greatest differences observed in βArnt GDM 
vs βArnt NDP offspring (Fig. 4b). This could be consistent with greater absorption of 
nutrients or fluid in GDM offspring. Interestingly, faecal output inversely correlated with 
maternal AUCGTT, suggesting that absorptive capacity may be influenced by in utero 
exposure (p  <  0.01, dns). 
	  
	  
GDM offspring had decreased metabolic rate, but not decreased locomotion 
GDM was associated with significantly decreased VO2at 6 weeks (Fig. 4c). This was associated 
with significantly reduced calculated energy expenditure for the whole day, and for the light 
hours during which mice usually rest (Fig. 4d). Ambulatory activity was non-significantly 
higher in GDM vs NDP offspring, so lower activity did not account for the decrease in energy 
expenditure (Fig. 4e). 
 
Respiratory exchange ratio was increased in GDM offspring 
Increased RER indicates preferential carbohydrate over lipid oxidation, and thus a propensity 
for lipid storage and increased adiposity [25]. An RER of 1.0 represents 100% carbohydrate 
oxidation, 0.7 represents 100% lipid oxidation [21]. RER did not differ between βArnt and 
floxed-control offspring. However, GDM exposure was associated with increased RER during 
light hours (1.03  ±  0.01 vs 0.99  ±  0.01, p  =  0.046) (Fig. 5a,	  b), with failure of the usual daytime 
switch to lipid oxidation. The fall in RER during light hours was significant, as expected, in 
NDP offspring (p  =  0.001, paired t test), but not in GDM offspring (p  =  0.608). There was a 
positive correlation between maternal gestational AUCGTT and offspring light hour RER. 
100% lipid oxidation [21]. RER did not differ between
βArnt and floxed-control offspring. However, GDM
exposure was associated with increased RER during light
hours (1.03±0.01 vs 0.99±0.01, p=0.046) (Fig. 5a, b),
with failure of the usual daytime switch to lipid oxidation.
The fall in RER during light hours was significant, as
expected, in NDP offspring (p=0.001, paired t test), but
not in GDM offspring (p=0.608). There was a positive
correlation between maternal gestational AUCGTT and
offspring light hour RER. Thus higher maternal glucose
correlated with lack of dip towards lipid oxidation (r2=
0.23, p<0.01) (Fig. 5c).
Insulin sensitivity was decreased and insulin secretion
pattern impaired in GDM offspring Consistent with our
previous report, βArnt offspring had worse glucose tolerance
than floxed-control offspring (p<0.01 at 8 and 16 weeks,
two-way ANOVA, 16 week GTT) (Fig. 6a). There was no
significant deterioration in glucose tolerance in GDM vs
NDP βArnt offspring or in GDM vs NDP floxed-control
offspring. Figure 6b shows fasting insulin concentrations in
the four offspring groups at 17 weeks. Fasting insulin was
significantly greater in GDM vs NDP offspring and also
greater in βArnt vs floxed-control offspring. This was
consistent with increased weight in GDM offspring.
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was lower in GDM offspring at 6 weeks of age (n=11 FC GDM, n=15
FC NDP, n=8 βArnt GDM, n=8 βArnt NDP); *p<0.05, **p<0.01 for
GDM vs NDP (ANOVA). d Energy expenditure (EE) at 6 weeks of age;
*p<0.05, **p<0.01 for GDM vs NDP (ANOVA). e Daily ambulatory
activity did not differ; †p=0.08. Data represent means±SEM. White
bars, FC NDP; grey bars, FC GDM; hatched bars, βArnt NDP; black
bars, βArnt GDM
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Thus higher maternal glucose correlated with lack of dip towards lipid oxidation (r2  =  0.23, 
p  <  0.01) (Fig. 5c). 
 
	  	  
Insulin sensitivity was decreased and insulin secretion pattern impaired in GDM offspring 
Consistent with our previous report, βArnt offspring had worse glucose tolerance than floxed-
control offspring (p  <  0.01 at 8 and 16 weeks, two-way ANOVA, 16 week GTT) (Fig. 6a). There 
was no significant deterioration in glucose tolerance in GDM vs NDP βArnt offspring or in 
GDM vs NDP floxed-control offspring. Figure 6b shows fasting insulin concentrations in the 
four offspring groups at 17 weeks. Fasting insulin was significantly greater in GDM vs NDP 
offspring and also greater in βArnt vs floxed-control offspring. This was consistent with 
increased weight in GDM offspring. 
 
	  	  
 Glucose-stimulated insulin secretion was abnormal in floxed-controls from GDM vs 
those from NDP, with impaired second-phase insulin release at 17 weeks (Fig. 6c) (130  ±  28 vs 
447  ±  363% of baseline, p  =  0.03, t test), although the residual secretion was sufficient to 
control glucose tolerance. In βArnt mice, GSIS was impaired, consistent with our previous 
100% lipid oxidation [21]. RER did not differ between
βArnt and floxed-control offspring. However, GDM
exposure was associated with increased RER during light
hours (1.03±0.01 vs 0.99±0.01, p=0.046) (Fig. 5a, b),
with failure of the usual daytime switch to lipid oxidation.
The fall in RER during light hours was significant, as
expected, in NDP offspring (p=0.001, paired t test), but
not in GDM offspring (p=0.608). There was a positive
correlation between maternal gestational AUCGTT and
offspring light hour RER. Thus higher maternal glucose
correlated with lack of dip towards lipid oxidation (r2=
0.23, p<0.01) (Fig. 5c).
Insulin sensitivity was decreased and insulin secretion
pattern impaired in GDM offspring Consistent with our
previous report, βArnt offspring had worse glucose tolerance
than floxed-control offspring (p<0.01 at 8 and 16 weeks,
two-way ANOVA, 16 week GTT) (Fig. 6a). There was no
significant deterioration in glucose tolerance in GDM vs
NDP βArnt offspring or in GDM vs NDP floxed-control
offspring. Figure 6b shows fasting insulin concentrations in
the four offspring groups at 17 weeks. Fasting insulin was
significantly greater in GDM vs NDP offspring and also
greater in βArnt vs floxed-control offspring. This was
consistent with increased weight in GDM offspring.
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βArnt NDP at 15 weeks). b Faecal weight (wt): food intake ratio,
animal numbers as above (a); *p<0.05 (t test) for βArnt GDM vs
βArnt NDP, **p<0.01 for GDM vs NDP offspring (ANOVA). c V
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was lower in GDM offspring at 6 weeks of age (n=11 FC GDM, n=15
FC NDP, n=8 βArnt GDM, n=8 βArnt NDP); *p<0.05, **p<0.01 for
GDM vs NDP (ANOVA). d Energy expenditure (EE) at 6 weeks of age;
*p<0.05, **p<0.01 for GDM vs NDP (ANOVA). e Daily ambulatory
activity did not differ; †p=0.08. Data represent means±SEM. White
bars, FC NDP; grey bars, FC GDM; hatched bars, βArnt NDP; black
bars, βArnt GDM
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presented as means±SEM. c Correlation between offspring light hours
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(Spearman bivariate correlation)
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Glucose-stimulated insulin secretion was abnormal in
floxed-controls from GDM vs those from NDP, with
impaired second-phase insulin release at 17 weeks
(Fig. 6c) (130±28 vs 447±363% of baseline, p=0.03, t
test), although the residual secretion was sufficient to
control glucose tolerance. In βArnt mice, GSIS was
impaired, consistent with our previous report (Fig. 6d),
but there was no further deterioration in GDM βArnt
offspring. Consistent with fasting insulin values, GDM
offspring at 15 weeks had mildly decreased insulin
sensitivity (Fig. 6e). As shown in Fig. 6f, insulin resistance
AUC (AUCITT) correlated with maternal glycaemia
AUCGTT (higher maternal AUCGTT, higher offspring
AUCITT, r2=0.30, p<0.001).
Altered arcuate neuropeptide expression in βArnt GDM
offspring We measured expression of Npy and Pomc
mRNA in the arcuate nucleus in 6-week-old offspring
using in situ hybridisation. Signal intensity was expressed
as a percentage of floxed-control NDP offspring.
There was no difference between floxed-control and
βArnt mice from NDP with respect to Npy or Pomc
expression. However, in βArnt, but not in floxed-control
mice, GDM caused a significant increase in Npy expression
and a significant decrease in Pomc expression (Fig. 7a, b).
Representative images are shown in Fig. 7c. In βArnt mice,
maternal gestational glucose tolerance correlated positively
with Npy expression (r2=0.78, p=0.002) (Fig. 7d) and
negatively with Pomc expression (r2=0.40, p=0.049).
Discussion
In this mouse model of GDM secondary to beta cell
dysfunction, we demonstrated an interaction between GDM
exposure and offspring genetic susceptibility to beta cell
dysfunction in causing male offspring obesity on a normal-
chow diet. Table 1 summarises the phenotypic differences
in offspring from GDM vs NDP. While both GDM
offspring groups developed obesity, βArnt offspring were
more severely affected, such that mice inheriting a
predisposition to glucose intolerance were more susceptible
to obesogenic effects of GDM than control-genotype mice.
Aspects of this model are relevant to human GDM. Thus
the glucose intolerance is secondary to impaired beta cell
function, with mice having worsening glycaemia in late
gestation with preserved normal fasting glucose. Beta cell
gene polymorphisms have been linked to type 2 diabetes
and GDM in humans; moreover, the gene we studied was
decreased in islets from three women with a known history
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Fig. 6 Glucose metabolism in offspring. a GTT at 16 weeks did not
differ between GDM and NDP offspring; **p<0.01 for βArnt vs
floxed-control (FC) offspring (ANOVA) (n=10 FC GDM, n=16 FC
NDP, n=8 βArnt GDM, n=12 βArnt NDP). b Fasting serum insulin at
17 weeks; *p<0.05 (ANOVA) for GDM vs NDP offspring and for
βArnt vs FC offspring. c GSIS was impaired in FC GDM (continuous
line) vs FC NDP (dotted line) at 17 weeks; *p<0.05 (t test). d GSIS
was impaired in all βArnt offspring (dotted line, βArnt NDP;
continuous line, βArnt GDM). e ITT at 15 weeks; *p<0.05 for
GDM vs NDP offspring (ANOVA). f Correlation between maternal
AUCGTT and offspring AUCITT; r2=0.30, p<0.001 (Spearman
bivariate correlation). Data represent means±SEM. Key (a, e): grey
diamonds, FC NDP; grey squares, FC GDM; white triangles βArnt
NDP; black squares, βArnt GDM
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report (Fig. 6d), but there was no further deterioration in GDM βArnt offspring. Consistent 
with fasting insulin values, GDM offspring at 15 weeks had mildly decreased insulin 
sensitivity (Fig. 6e). As shown in Fig. 6f, insulin resistance AUC (AUCITT) correlated with 
maternal glycaemia AUCGTT (higher maternal AUCGTT, higher offspring AUCITT, r2  =  0.30, 
p  <  0.001). 
 
Altered arcuate neuropeptide expression in βArnt GDM offspring  
We measured expression of Npy and Pomc mRNA in the arcuate nucleus in 6-week-old 
offspring using in situ hybridisation. Signal intensity was expressed as a percentage of floxed-
control NDP offspring. 
 There was no difference between floxed-control and βArnt mice from NDP with 
respect to Npy or Pomc expression. However, in βArnt, but not in floxed-control mice, GDM 
caused a significant increase in Npy expression and a significant decrease in Pomc expression 
(Fig. 7a,	  b). Representative images are shown in Fig. 7c. In βArnt mice, maternal gestational 
glucose tolerance correlated positively with Npy expression (r2  =  0.78, p  =  0.002) (Fig. 7d) 
and negatively with Pomc expression (r2  =  0.40, p  =  0.049). 
 
	  	  	   	  	  of GDM [18]. Another model that has examined interac-tions between maternal diabetes and offspring diabetes is
the GK rat. GK rats constitute a model of type 2 diabetes
secondary to reduced beta cell mass and function. Transfer
of GK embryos to Wistar dams did not improve offspring
glycaemia, showing that exposure to one generation of
normal glucose in utero did not change the GK phenotype
[11]. That study did not examine GK rats with no ancestral
exposure to GDM in prior generations.
Human studies also demonstrate genotype×pregnancy
interactions for offspring phenotype [26, 27]. People with
HNF1A MODY mutations were diagnosed with diabetes
earlier when their mothers had had diabetes prior to rather,
than after their birth [26]. A potential synergism between
maternal glucose intolerance and offspring genes is also
likely to be important in the normal wider population,
where offspring exposed to GDM will often inherit diabetes
susceptibility genes.
Exactly how GDM and diabetes in pregnancy increase
the risk of offspring obesity is not well understood. In this
study, male offspring developed spontaneous obesity on
normal chow. A separate cohort of offspring was studied
prior to development of the obese phenotype, demonstrat-
ing decreased metabolic rate and, in βArnt mice, changes in
hypothalamic Npy and Pomc expression prior to obesity.
Obesity was preceded by reduced energy expenditure,
rather than increased food consumption or decreased
locomotion, suggesting an intrinsic metabolic defect. This
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Discussion 
 
In this mouse model of GDM secondary to beta cell dysfunction, we demonstrated an 
interaction between GDM exposure and offspring genetic susceptibility to beta cell 
dysfunction in causing male offspring obesity on a normal-chow diet. Table 1 summarises the 
phenotypic differences in offspring from GDM vs NDP. While both GDM offspring groups 
developed obesity, βArnt offspring were more severely affected, such that mice inheriting a 
predisposition to glucose intolerance were more susceptible to obesogenic effects of GDM 
than control-genotype mice. 
 
	  	  	  
 Aspects of this model are relevant to human GDM. Thus the glucose intolerance is 
secondary to impaired beta cell function, with mice having worsening glycaemia in late 
gestation with preserved normal fasting glucose. Beta cell gene polymorphisms have been 
linked to type 2 diabetes and GDM in humans; moreover, the gene we studied was decreased 
in islets from three women with a known history of GDM [18]. Another model that has 
examined interactions between maternal diabetes and offspring diabetes is the GK rat. GK 
rats constitute a model of type 2 diabetes secondary to reduced beta cell mass and function. 
Transfer of GK embryos to Wistar dams did not improve offspring glycaemia, showing that 
exposure to one generation of normal glucose in utero did not change the GK phenotype [11]. 
That study did not examine GK rats with no ancestral exposure to GDM in prior generations. 
Human studies also demonstrate genotype  ×  pregnancy interactions for offspring phenotype 
[26, 27]. People with HNF1A MODY mutations were diagnosed with diabetes earlier when 
their mothers had had diabetes prior to rather, than after their birth [26]. A potential 
synergism between maternal glucose intolerance and offspring genes is also likely to be 
important in the normal wider population, where offspring exposed to GDM will often inherit 
diabetes susceptibility genes. 
 Exactly how GDM and diabetes in pregnancy increase the risk of offspring obesity is 
not well understood. In this study, male offspring developed spontaneous obesity on normal 
chow. A separate cohort of offspring was studied prior to development of the obese 
phenotype, demonstrating decreased metabolic rate and, in βArnt mice, changes in 
hypothalamic Npy and Pomc expression prior to obesity. Obesity was preceded by reduced 
energy expenditure, rather than increased food consumption or decreased locomotion, 
suggesting an intrinsic metabolic defect. This may be a central defect, as Npy expression was 
increased and Pomc expression decreased in the arcuate nucleus of βArnt GDM offspring, 
despite similar body weight, per cent body fat and leptin levels. Floxed-control GDM offspring 
had similar neuropeptide expression compared with their NDP counterparts. The overall 
findings suggest central dysregulation. 
 These data are consistent with previous studies suggesting that central regulation of 
body weight can be programmed in early life. Thus an inverse correlation between fat mass 
may be a central defect, as Npy expression was increased
and Pomc expression decreased in the arcuate nucleus of
βArnt GDM offspring, despite similar body weight, per
cent body fat and leptin levels. Floxed-control GDM
offspring had similar neuropeptide expression co pared
with their NDP counterparts. The overall findings suggest
central dysregulation.
These data are consistent with previous studi s suggest-
ing that cent al regulation of body weight can be
programmed in early lif . Thus an i verse correlation
between fat mass and leptin receptor expressio was
observed, with loss of the direct correlation between fat
mass and cocaine- and amphetamine-regulated transcript
(CART) levels in 30-day-old offspring of overfed ewes
[28]. Obese male offspring of rats with streptozotocin-
induced diabetes in pregnancy have increased neuropeptide
Y (NPY) neuron numbers [29]. Pro-opiomelanocortin- and
CART-secreting neurons were not examined in that study.
Respiratory exchange ratio has not been previously
reported in offspring of diabetic and GDM pregnancies. In
humans, increased RER or respiratory quotient is associated
with obesity and decreased lipid oxidation capacity predicts
weight gain [30, 31]. Thomas et al. showed that obese
individuals could ot increase th oxidation of lipids as
dietary fat ntake nc eased [32]. In normal mice, RER
decreases during the daytime when animals eat less an
switch from carbohydrate to lipid oxidation. GDM off-
spring did not demonstrate a reduction in light hours RER,
thus sustaining a preference for carbohydrate over lipid
oxidation over the entire 24 h period. These changes may
partly explain their increased adiposity and would be
consistent with increased expression of lipogenic and
insulin-signalling genes in epigonadal fat (favouring fat
accretion). Preferential fuel oxidation is also centrally
regulated [33]. The lack of normal circadian pattern in the
GDM offspring was interesting. Evidence suggests that the
adult sleep–wake cycle can be programmed by maternal
stress [34]. This work suggests the possibility that in utero
GDM exposure might affect programming of the adult
circadian metabolic clock and future studies in this area will
be of interest.
GDM offspring had decreased faecal output:food intake
ratio, suggest increased capacity for nutrient or fluid
absorption. Rece t human and animal studies linking gut
nutrient absorption capacity with obesity suggest that this
finding may contribute to an obese phenotype [35, 36].
Centrally administered NPY inhibits gastric emptying and
intestinal transit [37]. Thus increased Npy expression may
play a role in the decreased faeces:food weight ratio of
GDM offspring. Faeces:food ratio is an approximate
measure only, and further studies of the effects of GDM
exposure on gastrointestinal function could produce inter-
esting results.
An obvious limitation of this study is that offspring were
not cross-fostered. Thus this model did not separate the
effects of the intrauterine environment from the early-
postnatal environment. GDM mothers may have altered
milk composition or subtle differences in the care of their
offspring, which (if present) could impact on adult
offspring phenotype. Future studies determining whether
the effects are diminished by cross-fostering to normal
mothers would be of great interest. The offspring under-
went multiple metabolic tests (ITT, GTT and GSIS);
however, the tests were applied to all groups and mice
gained weight at expected trajectories.
In summary, this model of GDM resulted in spontaneous
offspring obesity associated with decreased energy expen-
diture prior to the onset of increased body weight, without
Variable Offspring per mother and pregnancy type
Floxed-control (NDP) βArnt (GDM pregnancy)
Floxed-control βArnt Floxed-control βArnt
NDP NDP GDM GDM
Body weight Normala Increaseda Normala Further increaseda
Body fat (%) Normala Increaseda Increaseda Further increaseda
Fasting insulin Normal Increased Normal Increased
Food intake Normal Normal or decreased Normal Normal
Energy expenditure Normal Decreased Normal Decreased
Locomotion Normal Normal Normal Normal
RER Normala Increaseda Normala Increaseda
V
!
O2 Normal Decreased Normal Decreased
Arcuate nucleus
Npy Normal Normal Normala Increased a
Pomc Normal Normal Normala Decreased a
Table 1 The effects of GDM
and offspring genotype on
offspring phenotype
a Correlated with maternal
AUCGTT
Diabetologia (2011) 54:910–921 919
Lau	  et	  al.:	  Diabetologia	  54	  (4):	  910-­‐921,	  2011	  
and leptin receptor expression was observed, with loss of the direct correlation between fat 
mass and cocaine- and amphetamine-regulated transcript (CART) levels in 30-day-old 
offspring of overfed ewes [28]. Obese male offspring of rats with streptozotocin-induced 
diabetes in pregnancy have increased neuropeptide Y (NPY) neuron numbers [29]. Pro-
opiomelanocortin- and CART-secreting neurons were not examined in that study. 
 Respiratory exchange ratio has not been previously reported in offspring of diabetic 
and GDM pregnancies. In humans, increased RER or respiratory quotient is associated with 
obesity and decreased lipid oxidation capacity predicts weight gain [30, 31]. Thomas et al. 
showed that obese individuals could not increase the oxidation of lipids as dietary fat intake 
increased [32]. In normal mice, RER decreases during the daytime when animals eat less and 
switch from carbohydrate to lipid oxidation. GDM offspring did not demonstrate a reduction 
in light hours RER, thus sustaining a preference for carbohydrate over lipid oxidation over the 
entire 24 h period. These changes may partly explain their increased adiposity and would be 
consistent with increased expression of lipogenic and insulin-signalling genes in epigonadal 
fat (favouring fat accretion). Preferential fuel oxidation is also centrally regulated [33]. The 
lack of normal circadian pattern in the GDM offspring was interesting. Evidence suggests that 
the adult sleep–wake cycle can be programmed by maternal stress [34]. This work suggests 
the possibility that in utero GDM exposure might affect programming of the adult circadian 
metabolic clock and future studies in this area will be of interest. 
 GDM offspring had decreased faecal output:food intake ratio, suggesting increased 
capacity for nutrient or fluid absorption. Recent human and animal studies linking gut 
nutrient absorption capacity with obesity suggest that this finding may contribute to an obese 
phenotype [35, 36]. Centrally administered NPY inhibits gastric emptying and intestinal 
transit [37]. Thus increased Npy expression may play a role in the decreased faeces:food 
weight ratio of GDM offspring. Faeces:food ratio is an approximate measure only, and further 
studies of the effects of GDM exposure on gastrointestinal function could produce interesting 
results. 
 An obvious limitation of this study is that offspring were not cross-fostered. Thus this 
model did not separate the effects of the intrauterine environment from the early-postnatal 
environment. GDM mothers may have altered milk composition or subtle differences in the 
care of their offspring, which (if present) could impact on adult offspring phenotype. Future 
studies determining whether the effects are diminished by cross-fostering to normal mothers 
would be of great interest. The offspring underwent multiple metabolic tests (ITT, GTT and 
GSIS); however, the tests were applied to all groups and mice gained weight at expected 
trajectories. 
In summary, this model of GDM resulted in spontaneous offspring obesity associated with 
decreased energy expenditure prior to the onset of increased body weight, without increased 
energy consumption or decreased locomotion. Obesity was preceded by hypothalamic 
dysregulation. 
 Human trials demonstrate that treating GDM reduces perinatal complication rates 
[38], with a linear relationship between maternal glycaemia and short-term offspring 
outcomes including birthweight [39]. We demonstrated a direct correlation between severity 
of maternal glucose intolerance and several measures of adult offspring phenotype, including 
adult offspring weight, body fat, insulin sensitivity and RER, as well as, in βArnt offspring, 
hypothalamic Npy and Pomc expression. There was no correlation between offspring 
phenotype and any other examined variables, including maternal weight, plasma 
triacylglycerol or pre-pregnancy glycaemia, suggesting that glucose was indeed the factor 
‘programming’ offspring phenotype. 
 These data suggest that the dose–response relationship between maternal glycaemia 
and short-term outcomes in offspring may also exist for longer term outcomes such as adult 
obesity. Taken together, these novel findings further our understanding of the pathogenesis of 
obesity in offspring exposed to GDM and provide evidence supporting tight control of 
maternal hyperglycaemia in humans with a view to avoiding long-term adverse outcomes in 
their offspring. 
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